Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1992 | 03-1992 | 12-1991 | 09-1991 | 06-1991 | |
| Sales | 1,478,300 | 1,557,100 | 1,572,600 | 1,341,300 | 1,376,300 |
| Cost of Goods | 445,600 | 435,100 | 547,700 | 392,300 | 388,200 |
| Gross Profit | 1,032,700 | 1,122,000 | 1,088,400 | 949,000 | 988,100 |
| Operating Expenses | 595,800 | 542,000 | 592,400 | 540,300 | 558,000 |
| Operating Income | 437,500 | 580,100 | 433,200 | 409,000 | 430,300 |
| Other Income | 49,000 | 56,800 | 12,300 | 16,000 | 23,200 |
| Pre-tax Income | 486,500 | 636,900 | 445,500 | 425,000 | 453,500 |
| Income Tax | 148,300 | 194,300 | 134,400 | 127,500 | 136,000 |
| Net Income Continuous | 340,200 | 444,700 | 311,100 | 297,500 | 317,500 |
| Net Income Discontinuous | -1,998,000 | -118,900 | 0 | 0 | 0 |
| Net Income | $340,200 | $325,800 | $311,100 | $297,500 | $317,500 |
| EPS Basic Total Ops | 0.29 | 0.38 | 0.27 | N/A | N/A |
| EPS Basic Continuous Ops | 0.29 | 0.38 | 0.27 | N/A | N/A |
| EPS Basic Discontinuous Ops | -1.70 | -0.10 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.29 | 0.28 | 0.27 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.29 | 0.38 | 0.27 | N/A | N/A |
| EPS Diluted Discontinuous Ops | -1.70 | -0.10 | N/A | N/A | N/A |
| EBITDA(a) | $437,500 | $580,100 | $433,200 | $409,000 | $430,300 |